Alertis Medical AS (Alertis) is a specialty medical devices company, engaged in the development of new technologies for biosensors, which are used for detecting vital changes in respiration and blood perfusion. The company holds the patent of a unique proprietary technology for detecting the tissue pCO2 level. The flagship product of the company IscAler is a miniaturized disposable biosensor which offers early warning of Ischemia. Its research and development activities are performed at Interventional Centre, Rikshospitalet-Radiumhospitalet, Norway. The company received 510-K clearance by the FDA for its products to be sold in the US and its products bear the CE mark for its distribution in the European Union. Alertis is headquartered in Oslo, Norway.

Street: 
Parkveien 53B
City: 
Oslo
Postcode: 
0256
Federal State : 
Norway
WebSite: 
www.alertis.no
Fax: 
47-21-013301

Company Index Score

Current Index Score Historical Index Score
  • Alertis Medical AS currently scores 50 % in the index.
  • Alertis Medical AS is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Alertis Medical AS is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets